Spalax Fibroblast Conditioned Medium Anti-Cancer Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments are inadequate for many types of cancer, and there is a need for effective anti-cancer agents that can target cancer cells without harming normal cells, as evidenced by the unique cancer-resistant properties of the Spalax mole rat.
Innovation Solution
Development of conditioned cell culture medium and biologically active fractions derived from Spalax or naked mole rat cells, which are used to identify and isolate anti-cancer agents that selectively kill or inhibit cancer cell proliferation while sparing normal cells, through methods involving cell culture, fractionation, and co-culture systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If current cancer treatments are used, then cancer cells can be targeted, but normal cells are also harmed
Solution Approach 1:
The invention segments the biological system by using Spalax fibroblasts as a selective source of anti-cancer factors. The conditioned medium contains specific bioactive molecules that segment the effect: they target cancer cells while sparing normal cells, achieving selective action through biological segmentation rather than broad-spectrum toxicity.
Solution Approach 2:
The Spalax fibroblast-conditioned medium acts as an intermediary substance that mediates the anti-cancer effect. Instead of directly applying toxic agents to cancer cells, the invention uses this conditioned medium as a mediator that selectively eliminates cancer cells while protecting normal cells, resolving the contradiction between targeting cancer and preserving normal tissue.
2Reliability
If Spalax fibroblasts are cultured to produce anti-cancer agents, then effective treatment can be obtained, but production complexity increases
Solution Approach 1:
The invention applies preliminary action by pre-culturing Spalax fibroblasts to generate conditioned medium containing anti-cancer factors before actual treatment. This preliminary culture step prepares the therapeutic agent in advance, allowing for controlled fractionation and identification of active components, thereby making the subsequent treatment process more reliable and manageable.
Solution Approach 2:
The invention extracts the active anti-cancer factors from the complex Spalax fibroblast-conditioned medium through fractionation. By taking out and isolating the specific bioactive molecules responsible for cancer cell killing, the invention simplifies the therapeutic agent into identifiable fractions that can be tested and applied, reducing the complexity of using whole cell extracts.
Data Source
AI summary
A conditioned cell culture medium of cells derived from Spalax or naked mole rat (Heterocephalus glaber) and methods for preparing it are provided. Pharmaceutical compositions comprising the conditioned cell culture medium and its use in the treatment of cancer as well as methods for identifying anti-cancer agents are also provided.